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risk among HIV infected contacts is needed for countries with moderate
TB incidence for future expansion of LTBI treatment in TB control
program.
Methods: We conducted a cohort study using contacts of active TB patients
from Taiwan TB registry during 2008e2012. All contacts were followed till
December 31, 2013 for developing active TB. We performed cross-link with
the contacts and both the nationwide HIV surveillance system and national
health insurance (NHI) claims database for other medical condition as risk
factors of TB. We used Cox proportional hazard model to estimate the haz-
ard ratio (HR) and 95% confidence interval (CI) for the association of TB risk
and HIV status among contacts.
Results: A total of 2328 (0.51%) active TB cases among 456,813 contacts
were found in our study. The overall incidence of contacts to develop active
TB was 162.76/100,000 person-year after the mean follow-up duration of 3.1
years. The TB incidence among HIV infected contacts was 574.8
(266.9e1091.0)/100,000, which is 3.54 (1.77e7.09) times of the risk among
non-HIV infected contacts. After adjusting potential confounders, HIV co-
infection (aHR: 2.89, 95% CI: 1.44e5.81) was independently associated
with active TB. Compared with non-HAART users, contacts receiving HAART
had lower risk to develop active TB but not statistically significant (p Z
0.512, log-rank test).
Conclusion: Contacts with HIV co-infection whether using HAART or not was
needed to be prioritized for contacts investigation, LTBI evaluation and
treatment.
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CESAREAN SECTION SURGICAL SITE INFECTION CAUSED BY
MYCOBACTERIUM MASSILIENSE
Hsiao-Chi Chang 1, Ting-Shu Wu 1,2,*, Ting-Ying Chung 1, Chun-Sui Lin 1,
Mao-Cheng Ge 1,3. 1Infection Control Committee, CGMH; 2Division of
Infectious Diseases, CGMH; 3Department of Laboratory Medicine, CGMH
Purpose: From August 1, 2012 to October 31, 2012, three patients whose C-
section surgical sites infected by Mycobacterium massiliense were reported.
We began an environmental surveillance and investigated the infection focus
for stopping further diseases clustering.
Materials: Our team of PCI investigated the whole process of preparedness
and disinfection of C-section. Environmental surveillance was performed
by ICPs. Further molecular epidemiological tool such as PFGE will be applied
for the investigation of clonality.
Results: No M. massiliense was cultivated from the environmental speci-
mens during this surveillance. After molecular analysis by PFGE, these 3 clin-
ical isolates were identified as the same clonality (Figure). It means that
these strains perhaps came from a common source.
Conclusions: A single clonality of these three isolates represented a prob-
able common infection source. After implementation of measures of PCI,
these medical materials became single-used. Until August 31, 2014, there
were no more new NTM related C-section surgical site infection.
Figure PFGE of three Mycobacterium massiliense isolates.OS 1-5
FIRST REPORT OF ONE NEGLECTED HYPERVIRULENT
(HYPERMUCOVISCOUS) AND PAN-SUSCEPTIBLE KLEBSIELLA PNEUMONIAE
ST86 STRAIN CAUSING FATAL INFECTIONS IN CHINA
Yibo Zhang 1, Yongzhang Zhu 2, Cenrong Mi 1, Wenhui Li 1, Qun Wang 1,
Dake Shi 1, Yuxing Ni 1. Department of Hospital Infection Control, Ruijin
Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
200025, China; Department of Immunology and Microbiology, Institutes of
Medical Sciences, Shanghai Jiao Tong University School of Medicine,
Shanghai, 200025, China
Purpose: In order to identified a hypervirulent (hypermucoviscous) and pan-
susceptible K. pneumoniae ST86 strain of serotype K2, responsible for two le-
thal bacteremia cases in a university teaching hospital in China.
Methods: We cultured and isolated K. pneumoniae from blood and/or
sputum samples from the 2 patients, which were labeled as Kp523 and
Kp562, respectively. A combination of Pulsed Field Gel Electrophoresis
(PFGE) and Multilocus sequence typing (MLST) methods was used to analyze
and compare molecular genetic characteristics of the two isolates. PCR was
performed to determine the presence of the specific wzx gene for capsule
serovar K1, K2, rmpA and magA.
Results: MLST typing revealed that the two strains belonged to same ST86.
PFGE typing analysis further showed that the two isolates displayed the
same PFGE profiles. We found that the two string test positive isolates
were also rmpA positive but magA negative using specific PCR primers tar-
geting rmpA and magA.
Conclusions: For the first time, we reported a distinct hypervirulent and
pan-susceptible K. pneumoniae serovar K2 ST86 strain, responsible for fatal
infections in a Chinese university teaching hospital.
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RESEARCH IN THE VIRULENCE OF CANDIDA
Shuxian Chen 1, Huiling Chen 2, Yaping Ahu 1. 1Dept. of Infection Control,
Guangzhou First People’s Hospital, Guangzhou, 510180; 2Dept. of Clinical
Laboratory, Guangzhou First People’s Hospital, Guangzhou, 510180
Purpose: Detecting the virulence’s level of lecithinase and hemolysis in
Candida, insight the correlative factors about the virulence of Candida.
Figure Characteristics identification of KP523 and KP562.
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from patients with Candida infection. We detected the virulence of Candida
by lecithinase test and hemolysis test. At the same time, the distribution
characteristics of different ages were analyzed among the patients.
Results: For the virulence, there were no difference between Candida albicans
and other Candidas (p > 0.05). The virulence of Candida albicans in deep infec-
tion were stronger than others in superficial infection(p < 0.01).
Conclusions: In the infection status, different strains of candida have the
same virulence’s level of lecithinase and hemolysis. The virulence of
Candida albicans relates to the infection site. The lecithinase test and he-
molysis test may be regarded as the evaluation index for testing the viru-
lence of Candida.
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ASPERGILLUS SPP. IN ICUS: SPECTRUM OF INFECTIONS WITH
ANTIFUNGAL SUSCEPTIBILITY PATTERNS OF CLINICAL AND
ENVIRONMENTAL ISOLATES
Yubhisha Dabas *, Immaculata Xess. Department of Microbiology, All India
Institute of Medical Sciences, New Delhi, India
Purpose: In this prospective study, we noted spectrum of infections with
Aspergillus spp. in ICU along with isolation of any environmental isolates
occurring in a Northern India tertiary care hospital during two years
(2011e2013) with antifungal susceptibility profiles of all isolates.
Methods: Phenotypic identification was done following standard mycological
procedures. Air sampling was done to collect environmental Aspergillus spp.
isolates from the ICUs. Antifungal susceptibility patterns to polyene, azole
and echinocandin group of drugs were tested by CLSI M38-A2 guidelines
and CLSI M51-A guidelines were followed for voriconazole.
Results: A total of 70 Aspergillus spp. clinical isolates were obtained from 60
patients. There were 35 Aspergillus fumigatus followed by 33 Aspergillus
flavus and 02 Aspergillus nidulans.
There were 08 environmental isolates obtained from the ICUs, 04 Aspergillus
fumigatus and 02 Aspergillus flavus and Aspergillus niger each. MICs were
lower for environmental isolates except one isolate of Aspergillus flavus
to caspofungin and itraconazole.
Conclusion:In our clinical settings, most common site of Aspergillus infec-
tions was pulmonary (90%). Aspergillus fumigatus was the commonest spe-
cies isolated which was at par with Aspergillus flavus (50% vs 45%).
Antifungal susceptibility testing revealed that voriconazole and posacona-
zole were sensitive to all the isolates suggesting these can be included in
the pre-emptive treatment of patients in ICUs.
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TOLL-LIKE RECEPTOR POLYMORPHISMS AS RISK FACTOR FOR
CLOSTRIDIUM DIFFICILE COLONIZATION AND INFECTION
Yuan-Pin Hung 1,2,3, Hsiao-Ju Lin 1,3,4, Pei-Jane Tsai 1,2,3,4,*, Wen-
Chien Ko 1,2,3,4,*. 1Department of Internal Medicine, Tainan hospital,
Ministry of Health and Welfare, Tainan, Taiwan; 2Department of Internal
Medicine, National Cheng Kung University Hospital, Tainan, Taiwan;
3Graduate Institute of Clinical Medicine, National Health Research
Institutes, Tainan, Taiwan; 4Department of Medical Laboratory Science and
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AMPHOTERICIN B (0.125- 1)
ITRACONAZOLE (0.0625- 8)
CASPOFUNGIN (0.125- ≥32)
MICAFUNGIN (0.06- ≥2)
POSACONAZOLE (0.0625-0.03)
VORICONAZOLE (0.0625-0.03)
VORICONAZOLE (38- 44*)
A.fumigatus SENSITIVE
A.fumigatus RESISTANT
A.flavus SENSITIVE
A.flavus RESISTANT
A.nidulans SENSITIVE
A.nidulans RESISTANT
No. of isolates
Figure 1 MIC range (mg/ml) of the Aspergillus spp. ICU clinical isolates.
(*zone diameter in mm)Biotechnology, National Cheng Kung University, Medical College, Tainan,
Taiwan
Purpose: Patients with TLR4 polymorphisms were more likely to have intes-
tinal infections due to gram-negative organisms. This study is to investigate
the impact of toll-like receptor (TLR) polymorphism on Clostridium difficile
colonization and infection.
Methods: Adults admitted to medical wards in a district hospital between
January 2011 and January 2013 were enrolled, and thosewith a history of colec-
tomy, C. difficile fecal colonization or infection or receipt of either metronida-
zole or oral vancomycin within 3 months, were excluded. Stools collected
within 48 hours after admission and every week during hospitalization were
cultured for C. difficile.
Results: Among the 445 enrolled patients, 92 (20.7%) developed toxic C.
difficile colonization (tCdC) and 21 (4.7) developed C. difficile associated
diarrhea (CDAD). The mortality rate was 13.7 %. There was no difference
in age, gender, receipt of antibiotics or proton-pump inhibitor or underly-
ing disease (including diabetes mellitus, hypertension, old stroke, chronic
kidney disease or having malignancy) among patients with different TLR4
rs1927914 polymorphism (GG, GA or AA type). We found TLR4 rs1927914
polymorphism A-carrier (including GA and AA) was associated with devel-
oping CDAD compared to GG type (4.9 and 5.2 vs 2.9 %, P Z 0.02) but not
correlated with tCDC or mortality. Other TLR4 polymorphism (rs10983755)
and three TLR2 SNPs (rs1898830, rs3804099, and rs7656411) were also
analyzed but not related to CDAD or tCDC.
Conclusions: The incidence of CDAD is highest in patients with the TLR4
rs1927914 polymorphism GA and AA genotype.
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MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME-OF-FLIGHT
MASS SPECTROMETRY FOR THE IDENTIFICATION OF BETA-HEMOLYTIC
STREPTOCOCCI
Chunmei Zhou 1, Lili Tao 2, Bijie Hu 3, Jian Ma 4, Xiangru Ye 5,
Shenglei Huang 1, Yan Ma 1, Yuzhang Shan 1. 1Deparment of Clinical
microbiology laboratory, Zhongshan Hospital, Fudan University;
2Department of Respiratory Medicine, Huadong Hospital, Fudan University;
3Department of Hospital Infection Control and management, Zhongshan
Hospital, Fudan University; 4Department of Respiratory Medicine, Yingzhou
Hospital, Ningbo University; 5Department of Respiratory Medicine,
Zhongshan Hospital, Fudan University
Purpose: To evaluate the application of two mostly utilized commercial
platforms of matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS) for the identification of clinical isolated
beta-hemolytic streptococci (BHS).
Methods: Clinical isolated BHS were identified by BD Phoenix SMIC/ID strep-
tococcal panels, Vitek MS system and Bruker MALDI Biotyper system, respec-
tively. In the case of discordant results, 16sRNA sequencing of the strains
was performed as reference ID.
Results: A total of 96 isolates of beta-haemolytic streptococci was
analyzed. 36 isolates were re-tested a second time to resolve no identifi-
cation results using the BD Phoenix system. Likewise, 4 isolates had to be
re-run on the Bruker system. Identification results were provided for all
96 isolates on the first test run using the VITEK MS system. The BD Phoenix
Toll-like receptor polymorphism-4 rs19279140 P values
GG n Z 68 GA n Z 205 AA n Z 172
C. difficile
colonization
20 (29.4) 41 (20.0) 31 (18.0) 0.14
C. difficile
associated
diarrhea
2 (2.9) 10 (4.9) 9 (5.2) 0.02
Mortality 9 (13.2) 35 (17.2) 17 (9.9) 0.12
